New CDC data: Osteoporosis rates increase in women … Exposed to COVID? Study finds point-of-care antibody tests highly effective at detection … Ruined J&J coronavirus vaccine doses are not in circulation:...
Clinical briefs for Thursday, Feb. 25
By
Alicia Lasek
Feb 25, 2021
Dementia care report should be ‘catalyst for change,’ committee says … Pain perception may be early disease marker in Alzheimer’s gene carriers … Nursing home first-dose vaccination data released...
Stronger coronavirus mutation may be new dominant strain, say scientists
By
Alicia Lasek
May 05, 2020
A newer, more contagious coronavirus mutation has become dominant worldwide, according to investigators from Los Alamos National Laboratory.
Clinical briefs for Monday, Feb. 27
By
Alicia Lasek
Feb 26, 2023
NIH: Spinal cord stimulation may restore arm and hand mobility after stroke … Screening rates for certain cancers must pick up after pandemic slowdown, analysts say … Antibiotics for COVID more commonly...
Bamlanivimab cuts risk of COVID in nursing homes and assisted living, study finds
By
Alicia Lasek
Jun 08, 2021
The investigation was conducted before the FDA revoked emergency use of the drug — a monoclonal antibody — due to the impact of genetic variants on efficacy. But it still can be used in combination...
Clinical Briefs for Thursday, April 2
By
Alicia Lasek
Apr 01, 2020
FDA orders all Zantac heartburn products off store shelves … Scientists discover gene that increases risk of Alzheimer’s disease … New CDC report adds evidence that underlying conditions raise...
AMA asks clinicians to reduce focus on BMI as health measure
Jun 15, 2023
The American Medical Association is encouraging clinicians to reduce their focus on body mass index. The measure is a flawed tool and should be considered alongside other measures such as genetics and...
Generic for Viagra holds promise as Alzheimer’s disease treatment, Cleveland Clinic researchers say
Dec 08, 2021
Users of sildenafil are 69% less likely to develop Alzheimer’s disease than their peers who do not use the drug, investigators report. A clinical trial to confirm its benefits for Alzheimer’s patients...
Clinical briefs for Wednesday, April 14
By
Alicia Lasek
Apr 14, 2021
NIH updates monoclonal antibody COVID treatment protocols … Surveyed community pharmacists say vaccine supply is bigger problem than patient reluctance … B.1.1.7 variant more transmissible but does...
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.